Review
Open access
Aug 2026
Surgical and pathologic efficacy of neoadjuvant immunochemotherapy in EGFR-mutant non-small cell lung cancer
Background Neoadjuvant immunochemotherapy (neo-ICT) has demonstrated promising pathological response for resectable non-small cell lung cancer (NSCLC), while its role in epidermal growth factor receptor (EGFR)-mutated NSCLC remains unclear. Here, we aim to explore whether patients with EGFR-sensitive mutation and posit...
Sang-Tian Liu, Qi-Lin Deng, Shi-Cui Quan et al.
· Translational Lung Cancer Re... · 0 citations